POU3F2 and melanoma: In the first, RNA expression profiling was performed in three BRAFV600E melanoma cell lines (MM370, MM603, and MM455) harboring doxycycline-inducible BRN2.62 Transcriptomes with and without BRN2 induction were compared, and Ingenuity Pathway Analysis (IPA, Qiagen) “upstream regulator” inference was applied.